Publication | Closed Access
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults
111
Citations
6
References
2005
Year
873140 demonstrated potent antiretroviral activity and was well tolerated. These results support further evaluation in Phase 2b/3 studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1